Virbac SA

Common Name

Virbac

Country

France

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

6,442

Ticker

VIRP

Exchange

Euronext Paris

Website

corporate.virbac.com

Description

Virbac SA is a French pharmaceutical company exclusively dedicated to animal health, founded in 1968 by veterinarian Pierre-Richard Dick. It manufactures and markets a comprehensive portfolio of produ... Show more

Income Statement Balance Sheet

Virbac's Financial Statements Preview

Below are the financial statements of Virbac, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of EUR	2024	2023
Goodwill	276.63^a	165.37^a
Intangible assets	251.24^a	185.11^a
Tangible assets	397.54^a	268.02^a
Right of use	36.86^a	32.94^a
Other financial assets	12.99^a	6.24^a
Share in companies accounted for by the equity method	4.51^a	4.24^a
Deferred tax assets	24.63^a	22.32^a
Non-current assets	1,004.4^a	684.25^a
Inventories and work in progress	404.17^a	339.66^a
Trade receivables	196.08^a	167.98^a
Other financial assets	4.31^a	2.64^a
Other receivables	89.93^a	85.3^a
Cash and cash equivalents	149.63^a	175.91^a
Current assets	844.12^a	771.48^a
Assets classified as held for sale	0^a	0^a
Assets	1,848.52^a	1,455.73^a
Share capital	10.49^a	10.57^a
Reserves attributable to the owners of the parent company	1,032.63^a	889.73^a
Equity attributable to the owners of the parent company	1,043.12^a	900.3^a
Non-controlling interests	0.29^a	9.62^a
Equity	1,043.4^a	909.92^a
Deferred tax liabilities	57.23^a	31.56^a
Provisions for employee benefits	20.36^a	19.61^a
Other provisions	8.9^a	7.3^a
Lease liability	26.55^a	25^a
Other financial liabilities	222.09^a	40.69^a
Other payables	5.43^a	22.61^a
Non-current liabilities	340.56^a	146.77^a
Other provisions	0.78^a	2.31^a
Trade payables	174.57^a	149.63^a
Lease liability	11.55^a	10.14^a
Other financial liabilities	57.98^a	47.71^a
Other payables	219.68^a	189.26^a
Current liabilities	464.56^a	399.05^a
Liabilities	1,848.52^a	1,455.73^a

Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources

pro

Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.

Download granular datasets (CSV/XLS)

Access underlying corporate disclosures (PDF)

Trace all values back to their original sources

Start Your 30-Day Free Trial

Formats Included

Excel

CSV

Json

All data fully traceable to original sources

Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Virbac’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Virbac's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Virbac SA

Virbac's Financial Statements Preview

Verified Sources Behind Virbac’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Kalbe Farma Tbk PT

Orion Oyj

GlaxoSmithKline Pharmaceuticals Ltd

Organon & Co

Roche Holding AG

Merck & Co Inc

Account Restricted